Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society
- PMID: 33239162
- DOI: 10.1016/j.numecd.2020.09.013
Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society
Abstract
Aims: This joint document of the Italian Society of Nephrology and the Italian Diabetes Society reviews the main indications to perform a renal biopsy in diabetic patients, according to the recommendations of a panel of experts based on all available scientific evidence.
Data synthesis: Renal biopsy has a pivotal role in assessing the nature and severity of renal injury in patients with diabetic kidney disease (DKD). The procedure is mandatory in the presence of one of more of the following features: rapid onset or progression of albuminuria or sudden onset of nephrotic syndrome, rapid GFR decline with or without albuminuria, hematuria, active urine sediment, clinical and/or laboratory suspicion of other systemic diseases, and, in patients with type 1 diabetes, short diabetes duration and absence of retinopathy. Indeed, ~40% of diabetic individuals with kidney injury undergoing renal biopsy are affected by a non-diabetic renal disease (NDRD). Furthermore, the histological evaluation of patients with suspected classical diabetic nephropathy allows to define the extent of glomerular, tubulo-interstitial and vascular lesions, thus providing important prognostic (and potentially therapeutic) data. In the future, the indications for renal biopsy might be extended to the definition of the histological lesions underlying the "nonalbuminuric" DKD phenotypes, as well as to the evaluation of the response to treatment with the new anti-hyperglycemic drugs that provide cardiorenal protection.
Conclusions: In view of the heterogeneous clinical presentation and course of DKD and of the related heterogeneous histopathological patterns, a more extensive use of renal biopsy may be crucial to provide valuable information with important pathogenic, diagnostic, prognostic, and therapeutic implications.
Keywords: DKD phenotypes; Diabetic kidney disease (DKD); Diabetic nephropathy (DN); Non-diabetic renal disease (NDRD); Renal biopsy.
Copyright © 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest LDN reported lecture and/or consultant fees from Astellas, AstraZeneca, Eli Lilly, MundiPharma, Janssen, Vifor Fresenius. AN reported consultant and/or lecture fees from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly and research grants from Boehringer Ingelheim, Eli Lilly. GPe reported lecture fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, Sigma-Tau and Takeda and travel grants from AstraZeneca, Novo Nordisk and Takeda. PF reported lecture and/or consultant fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, MundiPharma, and Novartis. GPu reported lecture and/or consultant fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, MundiPharma, Novartis, Novo Nordisk, Sigma-Tau, Takeda, and travel grants from AstraZeneca, Laboratori Guidotti, Sanofi, and Takeda. No other disclosures were reported.
Similar articles
-
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1127-1150. doi: 10.1016/j.numecd.2019.07.017. Epub 2019 Oct 2. Nutr Metab Cardiovasc Dis. 2019. PMID: 31586514 Review.
-
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".J Nephrol. 2020 Feb;33(1):9-35. doi: 10.1007/s40620-019-00650-x. J Nephrol. 2020. PMID: 31576500 Free PMC article. Review.
-
Clinical and histological correlation of diabetic nephropathy.Saudi J Kidney Dis Transpl. 2017 Jul-Aug;28(4):836-841. Saudi J Kidney Dis Transpl. 2017. PMID: 28748886
-
When to perform renal biopsy in patients with type2 diabetes mellitus? Predictive model of non-diabetic renal disease.Nefrologia (Engl Ed). 2020 Mar-Apr;40(2):180-189. doi: 10.1016/j.nefro.2019.07.005. Epub 2019 Nov 21. Nefrologia (Engl Ed). 2020. PMID: 31761446 English, Spanish.
-
Timing of kidney biopsy in type 2 diabetic patients: a stepwise approach.BMC Nephrol. 2020 Apr 15;21(1):131. doi: 10.1186/s12882-020-01794-w. BMC Nephrol. 2020. PMID: 32293326 Free PMC article.
Cited by
-
Plasma D-dimer levels are associated with disease progression in diabetic nephropathy: a two-center cohort study.Ren Fail. 2023;45(2):2285868. doi: 10.1080/0886022X.2023.2285868. Epub 2023 Nov 27. Ren Fail. 2023. PMID: 38013428 Free PMC article.
-
Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions.Biomedicines. 2024 May 15;12(5):1098. doi: 10.3390/biomedicines12051098. Biomedicines. 2024. PMID: 38791060 Free PMC article. Review.
-
A systematic review and Meta-analysis of urinary extracellular vesicles proteome in diabetic nephropathy.Front Endocrinol (Lausanne). 2022 Aug 11;13:866252. doi: 10.3389/fendo.2022.866252. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36034457 Free PMC article.
-
A Novel Risk Score Model for the Differential Diagnosis of Type 2 Diabetic Nephropathy: A Multicenter Study.J Diabetes Res. 2023 Dec 21;2023:5514767. doi: 10.1155/2023/5514767. eCollection 2023. J Diabetes Res. 2023. PMID: 38155834 Free PMC article. Clinical Trial.
-
Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study.Front Endocrinol (Lausanne). 2025 Jan 10;15:1451954. doi: 10.3389/fendo.2024.1451954. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39866738 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical